@CALifeSciences toured the Interdisciplinary Science Building @SJSU. The 164k SF facility is a state-of-the-art teaching & research space for molecular-microbiology-chemistry & applied data sciences. SJSU houses the largest clinical lab scientist program in CA. Great work SJSU!
We’re three weeks away from the Zoom course, From the Laboratory to Leadership 25th Anniversary Edition! This program addresses the unique challenges of the life sciences sector, providing a customized approach to meet your goals. Register: https://t.co/1iGPrZ7caX
In partnership with @JLABS, reps of NIA & NINDS will present an overview of the NIH SBIR program, NIA and NINDS funding opportunities, and special initiatives/resources for companies with innovative technologies. Apply by Jan 18 to meet one-on-one: https://t.co/7fRPnBFlDx
FAST California has helped more than 119 #startups--like @JALTherapeutics--with their business models, product development plans, and commercialization strategies. 🚀 APPLY by Jan 6 for our 2024 spring cohort: https://t.co/m2iz6gctyK #FosteringInnovation
🌟 Save the date for our inaugural Inclusive Leadership Symposium! Join #lifesciences leaders in San Francisco for a day of learning, reflection, and actionable change to embrace inclusion and equity. Register now: https://t.co/1CEr4I5WTL #HealthEquity#DEI#WeCommitToChange
We recently brought together #lifesciences executives in the San Diego region to meet with legislators and have conversations about our sector in California. We toured @bmsnews and @illumina, and we were delighted to have @SenToniAtkins & @AsmNguyen cohost dinner.
NEWS ALERT 👀 CLS is spotlighted in the latest @Axios story, "Silicon Valley's biotech sector is still going strong," with insights from our own Brent Fisk and data from our 2023 Sector Report! Read how the #lifesciences sector anchors the local economy: https://t.co/LH3J8HkV2N
Early bird pricing for the #WorldAgriTech Innovation Summit ends this week! It's the annual meeting place for the AgTech ecosystem. Expect start-up discovery, partnerships & investment opportunities and C-Suite networking. Use code CALIFRIEND to save: https://t.co/YlcYyuFTSn
Cell and gene therapies present unique reimbursement challenges, particularly for payers like Medicare. On pg 17 of Life Sciences Insights, @arnoldporter shares why CGT companies should learn current payment systems. READ: https://t.co/hLYzcfJAWq
#cellandgenetherapy
Economic slowdown? Great time to invest? Explore investment considerations in the cell and gene therapy market from David Crean of Cardiff Advisory, page 7 of Life Sciences Insights: https://t.co/zrJYI6JJmH
#cellandgenetherapy#investment#LifeSciencesInsights
Get expert support for your investigational new drug application (IND), new drug application (NDA) or biologics license application (BLA). Connect with @cardinalhealth's experienced team who has supported 90+ INDs & 155+ NDAs/BLAs in the past 5 years. https://t.co/p1QckID93G #ad
👋 We're happy to welcome one of our newest members, @Colliers! They're a real estate advisory group that represents & advises biotech users during the facility procurement process. Reach out for any requirements in the San Francisco Bay Area, San Diego, or Cambridge markets.
Are you a #lifesicences entrepreneur who's ready to build and hone your business model, product development plan, and commercialization strategy? We encourage you to apply for our advisory program, FAST California! Learn more and apply by January 5 👉https://t.co/I9kQeayMlX
📢 JUST LAUNCHED #2023HealthTrends: Personally, Purposely Building What's Next. @SyneosHealth releases 13th annual Trends detailing the technological evolution that will lead to profound changes in how organizations think about and learn from data.
https://t.co/Cn2Ct0IioV